23andMe Back From The Dead Thanks To Million-Dollar Grant And Your Genetic Data

The Google (NASDAQ:GOOG)-backed home genetic testing company 23andMe may be having a second life thanks to government interest in the genetic data collected by a product the FDA said was in violation of marketing regulations.